Argus Reiterates Buy Rating for Corteva (NYSE:CTVA)

Corteva (NYSE:CTVA)‘s stock had its “buy” rating reaffirmed by research analysts at Argus in a note issued to investors on Friday, Benzinga reports. They currently have a $91.00 price target on the stock. Argus’ price objective points to a potential upside of 14.69% from the company’s current price.

Several other analysts have also recently commented on CTVA. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Barclays upped their price objective on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Bank of America increased their price objective on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, Oppenheimer boosted their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $91.90.

Corteva Trading Down 1.3%

CTVA traded down $1.07 during midday trading on Friday, hitting $79.35. 3,489,012 shares of the company were exchanged, compared to its average volume of 4,195,670. The firm’s 50 day moving average price is $82.66 and its 200-day moving average price is $81.52. Corteva has a 1-year low of $60.53 and a 1-year high of $90.97. The firm has a market capitalization of $52.94 billion, a P/E ratio of 52.55, a P/E/G ratio of 2.47 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the prior year, the firm posted $2.20 earnings per share. The business’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts forecast that Corteva will post 3.72 EPS for the current fiscal year.

Institutional Investors Weigh In On Corteva

A number of large investors have recently bought and sold shares of CTVA. EFG International AG acquired a new stake in shares of Corteva in the 2nd quarter valued at about $25,000. Compass Financial Management LLC acquired a new position in Corteva during the 2nd quarter worth approximately $25,000. Cornerstone Financial Management LLC bought a new position in Corteva in the fourth quarter worth approximately $29,000. Elevation Wealth Partners LLC boosted its holdings in Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares in the last quarter. Finally, Basepoint Wealth LLC acquired a new stake in Corteva in the fourth quarter valued at approximately $30,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.